The PAR (Promotional Assessment Research) Reports —
PAR-Rx and PAR-Med
Created in 2000, with input from the nation's leading managed care pharmacy and medical executives, as well as from more than a dozen pharmaceutical companies, the CognetX PAR-Rx™ and PAR-Med™ Reports provide comprehensive, actionable, competitive intelligence and analysis throughout the year. PAR-Rx and PAR-Med clients receive customized, aggregated quarterly reports and analysis.
CognetX has stratified a unique panel of managed care pharmacy (PAR-Rx) and medical (PAR-Med) decision-makers at plans providing prescription drug benefits to the vast majority of Americans insured by a third party (Commercial, Medicare, and Medicaid). Reporting is ongoing throughout the year, ensuring the PAR-Rx and PAR-Med capture the latest market intelligence.
PAR-Rx and PAR-Med panels are comprised of individuals who:
- Routinely interact with drug company account personnel or clinical staff
- Have significant influence over the choice of products covered/paid for by their organization
Twice each year our panelists assess pharmaceutical/biotech companies in nine critical categories
The CognetX assessment methodology applied to the PAR-Rx and PAR-Med Reports is based on our proprietary Scale of Influence (SOI) model which helps clients understand the implications of panelists' rankings and the opportunities to move market share. Additionally, panelists' verbatims help explain why one company is considered the "very best" and another is considered "second best" or "third best." Please note, all data are aggregated and panelists/organizations are never identified.
At CognetX, our goal is to provide clients with the highest levels of expertise, service, support, training and customized data/analysis. The PAR-Rx and PAR-Med team is available to provide analytical support, consulting and executive briefings.